Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gnosis by Lesaffre, formerly known as Gnosis S.p.A. and often referred to as Gnosis Bioresearch, is a global business unit of the Lesaffre Group specializing in the development and manufacturing of fermentation-derived ingredients. The company focuses on three main areas: biopharmaceuticals, nutraceuticals, and functional foods, providing active ingredients such as folate, S-adenosylmethionine (SAMe), and Vitamin K2. With advanced manufacturing facilities in Italy and Switzerland, Gnosis utilizes microbial fermentation and chemical synthesis to produce high-quality bioactive compounds for the healthcare industry. Their portfolio includes well-known branded ingredients like Quatrefolic and Adonat, which are used globally in dietary supplements and pharmaceutical formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gnosis Bioresearch.